Pulling SEC filings + quote and writing the call…

VISA INC.
Next earnings Jul 27, 2026 (after close) · consensus $3.29 EPS, $11.6B rev
Last earnings -0.1% on 2026-04-28
Elite payments compounder — 60% op margins, 53% ROE — but ~33x earnings and a swelling interchange-litigation overhang cap the upside.
Revenue (FY2025) $40.0B · FY2025
Visa is one of the highest-quality franchises in public markets, and the filings confirm it. FY2025 net revenue grew 11.3% to $40.0B, extending a clean five-year ramp ($24.1B→$40.0B), and the business converts that revenue into cash like almost nothing else: a 60.0% operating margin, 50.1% net margin, 52.9% ROE, and $23.1B of operating cash flow against just $1.48B of capex (~$21.6B free cash flow). Management returned essentially all of it — $18.3B in buybacks and $4.63B in dividends. The MD&A describes the moat plainly: VisaNet processing across 200+ countries, with Visa carrying no credit risk because it 'does not issue cards, extend credit or set rates.' This is a toll-road on global money movement, not a lender.
The catch is twofold: price and litigation. GAAP net income grew just 1.6% despite 11.3% revenue growth, because GAAP operating expenses jumped 30% — driven, per the MD&A, by a $2.2B additional accrual for the interchange multidistrict litigation plus higher personnel costs. Strip that out and management's non-GAAP net income rose 11% and non-GAAP diluted EPS rose 14% to $11.47, so the underlying earnings engine is intact. But the litigation is a live, open-ended overhang: Visa booked $2.2B of new accruals and deposited another $875M into the U.S. escrow, and explicitly warns the accruals 'could be higher or lower' than deposits, with future class B exchange offers gated on a 50%+ reduction in disputed reimbursement fees. The balance sheet shows the strain — current liabilities surged 32.2% and retained earnings fell 12.6%.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 29, 2026, 8:26 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $24.1B | $29.3B | $32.7B | $35.9B | $40.0B |
| Gross profit | — | — | — | — | — |
| Operating income | $15.8B | $18.8B | $21.0B | $23.6B | $24.0B |
| Net income | $12.3B | $15.0B | $17.3B | $19.7B | $20.1B |
| Diluted EPS | — | — | — | — | — |
| Net margin | 51.1% | 51.0% | 52.9% | 55.0% | 50.1% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Item 8.01 other-event disclosure; no financial impact quantified for shareholders
Entered a material definitive agreement (Item 1.01) plus other-event disclosure
Reg FD investor/conference disclosure with exhibits; informational only
Q2 FY26 (Mar-26): payments/processing volumes keep compounding revenue
Q2 FY26 earnings release (Item 2.02); continued double-digit revenue growth
Item 8.01 other-event disclosure; no quantified shareholder impact
Reg FD disclosure (Item 7.01); informational, no financial change
Q1 FY26 (Dec-25): revenue growth continues on transaction and cross-border gains
Annual proxy: board, exec pay and governance items up for shareholder vote
Sources: SEC EDGAR (CIK 0001403161, latest 10-Q filed 2026-04-29) · EODHD · Proprietary analysis · as of 6/29/2026, 12:26:08 PM.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 0 open-market buys · 5 sales
| 2026-07-01 | MCINERNEY RYAN Chief Executive Officer | Exercise | 10.5K @ $109.82 | $1.15M |
| 2026-07-01 | MCINERNEY RYAN Chief Executive Officer | Sell | 8.85K @ $343.88 | $3.04M |
| 2026-07-01 | MCINERNEY RYAN Chief Executive Officer | Sell | 1.64K @ $344.55 | $564K |
| 2026-06-29 | MCINERNEY RYAN Chief Executive Officer | Exercise | 21.0K @ $109.82 | $2.30M |
| 2026-06-29 | MCINERNEY RYAN Chief Executive Officer | Sell | 21.0K @ $340.25 | $7.13M |
| 2026-05-12 | Suh Chris CHIEF FINANCIAL OFFICER | Sell | 10.6K @ $324.81 | $3.46M |
| 2026-04-29 | MCINERNEY RYAN Chief Executive Officer | Exercise | 31.5K @ $109.82 | $3.45M |
| 2026-04-29 | MCINERNEY RYAN Chief Executive Officer | Sell | 31.5K @ $340.14 | $10.7M |
| 2026-03-11 | CARNEY LLOYD Director | Sell | 650.00 @ $309.62 | $201K |
| 2026-02-15 | Taneja Rajat PRESIDENT, TECHNOLOGY | Exercise | 35.5K | |
| 2026-02-15 | Taneja Rajat PRESIDENT, TECHNOLOGY | Tax | 17.6K @ $314.08 | $5.53M |
| 2026-02-15 | MAHON TULLIER KELLY VICE CHAIR, CHF PPL & CORP AFF | Exercise | 35.5K |
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
6 buys · 2 sells · 4 members · last 180d
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.